Holen Sie sich die Stockscreener-App
9.31
2.08%
0.19
Schlusskurs vom Vortag:
$9.12
Offen:
$9.22
24-Stunden-Volumen:
295.95K
Relative Volume:
0.52
Marktkapitalisierung:
$323.06M
Einnahmen:
$2.07M
Nettoeinkommen (Verlust:
$-47.68M
KGV:
-3.3014
EPS:
-2.82
Netto-Cashflow:
$-31.31M
1W Leistung:
-0.64%
1M Leistung:
-10.65%
6M Leistung:
-16.20%
1J Leistung:
-42.81%
1-Tages-Spanne:
$9.13
$9.55
1-Wochen-Bereich:
$8.94
$10.30
52-Wochen-Spanne:
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Firmenname
Delcath Systems Inc
Sektor
Branche
Telefon
(518) 743-8892
Adresse
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
9.31 | 316.46M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2022-07-26 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-03-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-01-05 | Eingeleitet | BTIG Research | Buy |
| 2020-06-01 | Eingeleitet | Laidlaw | Buy |
Alle ansehen
Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten
Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call - BioSpace
Is Delcath Systems Inc. a strong candidate for buy and hold2025 Support & Resistance & Daily Stock Trend Reports - mfd.ru
Will Delcath Systems Inc. stock recover faster than peers2025 Biggest Moves & AI Driven Price Forecasts - mfd.ru
Clear Street Raises Delcath Systems, Inc. (DCTH) Target to $29, Maintains Buy Rating - Insider Monkey
10 Best Long Term Healthcare Stocks to Buy - Insider Monkey
Fund Flows: Is Delcath Systems Inc subject to activist investor interestWeekly Investment Report & Risk Controlled Swing Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (DCTH) Edition - Stock Traders Daily
Canaccord Genuity Sticks to Their Buy Rating for Delcath Systems (DCTH) - The Globe and Mail
The Robot Revolution Is Here: Stocks to Consider from Tesla, Hyundai, and Others. - Intellectia AI
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Delcath Systems Faces Valuation Shift Amidst Mixed Financial Indicators and Growth Trends - Markets Mojo
Aug Gainers: Can Delcath Systems Inc continue delivering strong returns2025 Year in Review & Capital Efficient Trade Techniques - baoquankhu1.vn
Can Delcath Systems Inc. continue delivering strong returnsJuly 2025 Closing Moves & Safe Entry Momentum Tips - mfd.ru
Liver cancer-focused Delcath joins BTIG MedTech, digital health conference - Stock Titan
Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Yahoo Finance
(DCTH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Analysis Recap: Is CYCCP forming a double bottomMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Retail Surge: Can Delcath Systems Inc continue delivering strong returnsQuarterly Portfolio Review & Consistent Return Investment Signals - baoquankhu1.vn
Returns On Capital Are Showing Encouraging Signs At Delcath Systems (NASDAQ:DCTH) - Yahoo Finance
Delcath Systems, Inc. (DCTH) Stock Analysis: A 103% Upside Potential In Medical Devices - DirectorsTalk Interviews
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 21, 2026 - BioSpace
Delcath Systems, Inc. announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Is Delcath Systems Inc backed by strong institutional buyingLong Setup & Daily Growth Stock Investment Tips - baoquankhu1.vn
UTSW first in Texas to offer novel treatment for rare eye cancer that spreads to the liver : Newsroom - UT Southwestern
Market Catalysts: Is ODYS forming a bullish divergenceEarnings Performance Report & Real-Time Buy Signal Notifications - baoquankhu1.vn
Price-Driven Insight from (DCTH) for Rule-Based Strategy - Stock Traders Daily
Delcath Systems expects FY revenue of $85.2 million - MSN
Delcath Systems: Stabilizing Fundamentals Justify A Rating Upgrade (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems Reports Strong Preliminary 2025 Results - TipRanks
NY-based Delcath Systems expects Q4 2025 revenue to hit USD 20.7M - Medical Buyer
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Q2 2025 Earnings Call Transcript - MSN
EBITDA per share of Delcath Systems, Inc. – DUS:DV3R - TradingView — Track All Markets
Delcath reports $85.2 million in 2025 revenue, strong cash position By Investing.com - Investing.com Nigeria
Delcath Systems (NASDAQ:DCTH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
DCTH FinancialsIncome Statement - Quiver Quantitative
DCTH: HC Wainwright Reiterates Buy Rating with $30 Price Target - GuruFocus
HC Wainwright Reaffirms Buy Rating for Delcath Systems (NASDAQ:DCTH) - MarketBeat
Delcath Systems, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2025 - MarketScreener
Delcath Systems (DCTH) Exceeds Revenue Expectations in Q4 and Fu - GuruFocus
Delcath Systems announces preliminary fourth quarter and full year 2025 financial results - marketscreener.com
Delcath reports $85.2 million in 2025 revenue, strong cash position - Investing.com
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - The AI Journal
Will Delcath Systems Inc. stock outperform Nasdaq indexWeekly Market Report & Fast Entry Momentum Alerts - ulpravda.ru
ETF Watch: Will Delcath Systems Inc. stock remain a Wall Street favoriteTrade Ideas & Reliable Price Breakout Signals - Улправда
How resilient is Delcath Systems Inc. stock in market downturnsJuly 2025 Retail & Weekly Top Gainers Alerts - ulpravda.ru
Will Delcath Systems Inc. stock remain a Wall Street favoriteMarket Volume Summary & Daily Technical Forecast Reports - Улправда
Shorts Report: Will Delcath Systems Inc stock remain a Wall Street favorite2025 Earnings Impact & Daily Growth Stock Investment Tips - Bộ Nội Vụ
Finanzdaten der Delcath Systems Inc-Aktie (DCTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Delcath Systems Inc-Aktie (DCTH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MICHEL GERARD J | CHIEF EXECUTIVE OFFICER |
Nov 11 '25 |
Buy |
8.53 |
11,500 |
98,049 |
330,834 |
| Vukovic Vojo | CHIEF MEDICAL OFFICER |
Jun 12 '25 |
Option Exercise |
4.78 |
42,000 |
200,760 |
168,882 |
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):